Labeling of sarcoma associated monoclonal antibody with (111)In, (67)Ga and (125)I Journal Article


Authors: Lavie, E.; Boazi, M.; Weininger, J.; Bitton, M.; Yosilevski, G.; Front, D.; Hirshaut, Y.; Robinson, E.; Bartal, A. H.
Article Title: Labeling of sarcoma associated monoclonal antibody with (111)In, (67)Ga and (125)I
Abstract: Labeling of human sarcoma-associated murine monoclonal antibody (MAb) 23H7 with 67Ga and 111In by the bifunctional ligand method is reported. 67Ga was chelated to the MAb via desferrioxamine B and 111In via the cyclic anhydride of DTPA. Higher specific activity was obtained with 67Ga (4-5 μCi/μg) as compared with 111In (2 μCi/μg). The binding capacity of the MAb was confirmed by repeated indirect immuno-fluorescence assays performed before and after labeling. A fast blood clearance was observed: 33% recovered dose (R.D.) blood level 3 h post-injection as compared with 56% after injection of control polyclonal IgG. Preliminary results on chemically induced sarcoma bearing mice showed a relatively high tumor uptake of the labeled antibody. © 1987 Elsevier Science Publishers B.V. (Biomedical Division).
Keywords: unclassified drug; human cell; animals; mice; immunofluorescence; monoclonal antibody; drug receptor binding; sarcoma; soft tissue; antibodies, monoclonal; isotope labeling; tissue distribution; iodine radioisotopes; radioisotope; radioisotopes; antibodies, neoplasm; deferoxamine mesylate; deferoxamine; sarcoma, experimental; indium; gallium radioisotopes; monoclonal antibody in 111; humans; human; priority journal; monoclonal antibody i 125; monoclonal antibody labeling; monoclonal antibody ga 67
Journal Title: Radiotherapy and Oncology
Volume: 8
Issue: 2
ISSN: 0167-8140
Publisher: Elsevier Inc.  
Date Published: 1987-01-01
Start Page: 129
End Page: 135
Language: English
DOI: 10.1016/s0167-8140(87)80166-4
PUBMED: 3562892
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 5 February 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics